APA

Rousselle C., Smirnova M., Clair P., Lefauconnier J. M., Chavanieu A., Calas B., Scherrmann J. M. & Temsamani J. (20010202). Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. : The Journal of pharmacology and experimental therapeutics.

Chicago

Rousselle C, Smirnova M, Clair P, Lefauconnier J M, Chavanieu A, Calas B, Scherrmann J M and Temsamani J. 20010202. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. : The Journal of pharmacology and experimental therapeutics.

Harvard

Rousselle C., Smirnova M., Clair P., Lefauconnier J. M., Chavanieu A., Calas B., Scherrmann J. M. and Temsamani J. (20010202). Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. : The Journal of pharmacology and experimental therapeutics.

MLA

Rousselle C, Smirnova M, Clair P, Lefauconnier J M, Chavanieu A, Calas B, Scherrmann J M and Temsamani J. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. : The Journal of pharmacology and experimental therapeutics. 20010202.